1292902-56-7 Usage
Uses
Used in Organic Synthesis:
(S)-Methyl-(tetrahydro-furan-3-yl)-amine is utilized as a building block in organic synthesis for its ability to form a variety of complex molecules. Its cycloalkyl group and secondary amine functionality provide a versatile platform for the construction of diverse chemical entities.
Used in Pharmaceutical Chemistry:
In the pharmaceutical industry, (S)-Methyl-(tetrahydro-furan-3-yl)-amine is employed as a key component in the synthesis of pharmaceuticals. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used as a Chiral Auxiliary in Asymmetric Synthesis:
(S)-Methyl-(tetrahydro-furan-3-yl)-amine is used as a chiral auxiliary in asymmetric synthesis to facilitate the production of enantiomerically pure compounds. This is crucial in pharmaceuticals, where the desired biological activity is often associated with a specific enantiomer, and the undesired enantiomer may have adverse effects.
Used in the Creation of Complex Molecules:
(S)-Methyl-(tetrahydro-furan-3-yl)-amine's reactivity and structural features make it instrumental in the synthesis of complex molecules, which are essential in various chemical and biological applications, including the development of new materials and the study of molecular interactions.
Check Digit Verification of cas no
The CAS Registry Mumber 1292902-56-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,9,2,9,0 and 2 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1292902-56:
(9*1)+(8*2)+(7*9)+(6*2)+(5*9)+(4*0)+(3*2)+(2*5)+(1*6)=167
167 % 10 = 7
So 1292902-56-7 is a valid CAS Registry Number.
1292902-56-7Relevant academic research and scientific papers
PIKFYVE KINASE INHIBITORS
-
Page/Page column 249, (2021/08/20)
The present invention relates to compounds useful as inhibitors of phosphatidylinositol-3-phosphate 5-kinase (PIKfyve) as well as their use for treating diseases and disorders associated with PIKfyve.
Quinazoline derivatives and phamaceutical compositions containing them
-
, (2008/06/13)
A compound of general formula I wherein: Ra is a benzyl, 1-phenylethyl, or 3-chloro-4-fluorophenyl group; Rb is a dimethylamino, N-methyl-N-ethylamino, diethylamino, N-methyl-N-isopropylamino, N-methyl-N-cyclopropylamino, N-methyl-N-(2-methoxyethyl)amino, N-ethyl-N-(2-methoxyethyl)amino, bis(2-methoxyethyl)amino, morpholino, N-methyl-N-(tetrahydrofuran-3-yl)amino, N-methyl-N-(tetrahydrofuran-2-ylmethyl)amino, N-methyl-N-(tetrahydrofuran-3-ylmethyl)amino, N-methyl-N-(tetrahydropyran-4-yl)amino, or N-methyl-N-(tetrahydropyran-4-ylmethyl)amino group; and Rc is a cyclopropylmethoxy, cyclobutyloxy, cyclopentyloxy, tetrahydrofuran-3-yloxy, tetrahydrofuran-2-ylmethoxy, tetrahydrofuran-3-ylmethoxy, tetrahydropyran-4-yloxy, or tetrahydropyran-4-ylmethoxy group, or a tautomer, stereoisomer, or salt thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases which have valuable pharmacological properties, in particular an inhibitory effect on signal transduction mediated by tyrosine kinases, their use in the treatment of diseases, especially tumoral diseases and diseases of the lungs and airways, and the preparation thereof.
